Your browser is no longer supported. Please, upgrade your browser.
Settings
ABT Abbott Laboratories daily Stock Chart
ABT [NYSE]
Abbott Laboratories
IndexS&P 500 P/E56.43 EPS (ttm)0.90 Insider Own0.70% Shs Outstand1.73B Perf Week3.95%
Market Cap87.82B Forward P/E18.45 EPS next Y2.76 Insider Trans-3.17% Shs Float1.72B Perf Month4.67%
Income1.39B PEG5.10 EPS next Q0.61 Inst Own73.40% Short Float1.02% Perf Quarter16.79%
Sales22.30B P/S3.94 EPS this Y-58.60% Inst Trans-0.07% Short Ratio2.76 Perf Half Y25.65%
Book/sh18.16 P/B2.80 EPS next Y11.76% ROA3.00% Target Price51.38 Perf Year18.12%
Cash/sh5.13 P/C9.91 EPS next 5Y11.06% ROE6.40% 52W Range37.38 - 51.13 Perf YTD32.36%
Dividend1.06 P/FCF79.40 EPS past 5Y0.00% ROI6.70% 52W High-0.57% Beta1.57
Dividend %2.08% Quick Ratio2.30 Sales past 5Y-0.50% Gross Margin55.50% 52W Low36.01% ATR0.69
Employees75000 Current Ratio2.90 Sales Q/Q29.70% Oper. Margin11.00% RSI (14)74.87 Volatility1.55% 1.33%
OptionableYes Debt/Eq0.76 EPS Q/Q489.40% Profit Margin6.70% Rel Volume1.26 Prev Close50.85
ShortableYes LT Debt/Eq0.76 EarningsJul 20 BMO Payout107.00% Avg Volume6.36M Price50.84
Recom1.90 SMA204.24% SMA508.36% SMA20017.94% Volume7,980,202 Change-0.02%
Jun-29-17Resumed Jefferies Buy
Jun-29-17Initiated Guggenheim Buy $58
Jun-21-17Resumed BTIG Research Buy $56
May-16-17Initiated Goldman Neutral $45
Apr-20-17Reiterated Barclays Overweight $50 → $52
Mar-01-17Reiterated RBC Capital Mkts Outperform $46 → $50
Jan-26-17Reiterated RBC Capital Mkts Outperform $48 → $46
Jul-21-16Reiterated Barclays Overweight $48 → $50
Jun-21-16Upgrade Edward Jones Hold → Buy
Apr-11-16Reiterated RBC Capital Mkts Outperform $45 → $48
Jan-04-16Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-07-15Upgrade Jefferies Hold → Buy
Nov-13-15Downgrade Goldman Buy → Neutral
Oct-09-15Reiterated RBC Capital Mkts Outperform $55 → $51
Oct-07-15Upgrade Barclays Equal Weight → Overweight $55 → $52
Jul-23-15Reiterated Stifel Buy $53 → $58
Jul-23-15Reiterated RBC Capital Mkts Outperform $51 → $55
Jul-23-15Reiterated Barclays Equal Weight $53 → $55
Apr-23-15Reiterated Stifel Buy $52 → $53
Mar-27-15Reiterated Barclays Equal Weight $48 → $52
Jul-21-17 02:47PM  Abiomed Impella Quality Program Will Boost Demand in Fiscal 2018 Market Realist
02:35PM  Behind the Major Drivers of JNJs Medical Device Growth Market Realist
10:40AM  Inside Abiomeds Profit Margin Expectations for Fiscal 2018 Market Realist
09:51AM  Company News for July 21, 2017 Zacks
08:00AM  Today's Research Reports on Stocks to Watch: Abbott Laboratories and Pfizer Inc. Accesswire
12:35AM  Abbott tops Street 2Q forecasts Associated Press
Jul-20-17 06:02PM  LabCorp (LH) Q2 Earnings: Is Disappointment in the Cards? Zacks
05:47PM  Abiomed in 2017: The Analysts View Market Realist
04:09PM  Markets Right Now: US struggle to a mixed finish Associated Press
04:09PM  Markets Right Now: US struggle to a mixed finish Associated Press
04:03PM  Abbott Zeros In On A 2-Year High After Topping Q2 Sales, Profits Investor's Business Daily
01:05PM  US STOCKS-S&P, Dow flat as retailers weigh; Nasdaq edges higher Reuters
12:35PM  Abbott profit forecast gets a lift from St. Jude integration Reuters
12:34PM  Abbott Labs (ABT) Beats on Q2 Earnings and Sales, View Up Zacks
12:00PM  Abbott CEO: Another Alere-Related Divestiture Coming Soon TheStreet.com
11:25AM  US STOCKS-Wall St flat as consumer stocks, weak earnings weigh Reuters
10:10AM  US STOCKS-Wall St flat as earnings from some big names disappoint Reuters
09:30AM  Abbott (ABT) Tops Earnings Estimates in Q2, Misses on Sales Zacks
08:49AM  US STOCKS-Wall St set to open higher on earnings optimism Reuters
07:56AM  Abbott's quarterly profit halves as costs soar Reuters
07:45AM  Abbott Reports Second-Quarter 2017 Results PR Newswire
Jul-19-17 03:56PM  Alere, St. Jude Deals in Focus as Abbott Releases Q2 Earnings TheStreet.com
09:52AM  Medical Product Stocks' Earnings on Jul 20: ABT, ISRG & More Zacks
Jul-18-17 05:21PM  Quidel Diversifies With Alere's Triage Assets TheStreet.com
02:27PM  Abbott's Tarnished Deal Sparkles for Another Bloomberg
Jul-17-17 05:29PM  Chartmaster says these are the 3 names you should buy on ... CNBC Videos
10:25AM  Science: Sugar substitute effects not so sweet American City Business Journals
10:20AM  3 Big Stock Charts for Monday: Qualcomm, Inc. (QCOM), Abbott Laboratories (ABT) and Microsoft Corporation (MSFT) InvestorPlace
08:45AM  Can Abbott Laboratories (ABT) Pull a Surprise in Q2 Earnings? Zacks
08:17AM  Abbott Commences Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. PR Newswire
07:38AM  Abbott Laboratories Dividend Growth and Payout Potential in 2017 Market Realist
Jul-14-17 04:05PM  What to Expect from Abbott Laboratories 2Q17 Earnings Market Realist
02:35PM  Will Abbott Laboratories Beat Analyst Revenue Estimates in Q2? Market Realist
01:05PM  ABT: Wall Street Analysts Recommendations ahead of Q2 Earnings Market Realist
07:01AM  Abbott Partners Bigfoot Biomedical to Expand in Diabetics Zacks
Jul-13-17 01:43PM  Abbott Laboratories Is Set for Another Breakout TheStreet.com
07:30AM  Abbott and Bigfoot Biomedical Announce Collaboration to Develop Breakthrough Diabetes Technologies PR Newswire
Jul-12-17 10:24AM  Edwards Emerges Strong on FDA Nods, International Prospect Zacks
10:09AM  LabCorp Diagnostics Strong on Novant Health Deal Extension Zacks
Jul-11-17 07:40AM  Featured Company News - Alere Announces Approval of Amended Merger Agreement by Shareholders with Abbott Labs Accesswire
Jul-10-17 12:45PM  A Look at Abbott Laboratories Stock for 2Q17 Market Realist
10:13AM  Thermo Fisher at a 52-Week High: What's Driving the Stock? Zacks
09:44AM  Investors Look for Gains as Abbott Labs Set to Acquire Alere Zacks
Jul-07-17 05:14PM  MedTech Thriving on Consolidation & Expansion: Stocks to Buy Zacks
04:40PM  Alere Shareholders Vote to Approve Amended Merger with Abbott TheStreet.com
07:25AM  Phibro Animal Health & Zydus Cadila Plan to Expand in India Zacks
Jul-06-17 02:05PM  Behind Johnson & Johnsons Recent Medical Device Launches Market Realist
09:50AM  Exactech Boosts Knee System Portfolio, Launches New App Zacks
09:46AM  Here's Why You Should Add Abbott Laboratories Right Now Zacks
Jul-05-17 09:09AM  Abbott Freestyle Libre System Gets Health Canada License Zacks
Jul-03-17 09:08AM  Abbotts Freestyle Libre Gets Reimbursement Approval in France Market Realist
07:38AM  Abbotts Nutrition Segment: Chinese Headwinds Continue Market Realist
Jun-30-17 12:48PM  [$$] Abbott Labs May Raise Guidance Barrons.com
10:39AM  How BSXs Deep Brain Stimulation Portfolio Is Expanding Market Realist
10:38AM  Abbotts Acquisitions Are Its Major Growth Drivers Market Realist
09:08AM  Abbott Gets CE Marking: TactiCath Contact Force Ablation Catheter Market Realist
07:38AM  Technological Advancements Drive Abbotts New Product Approvals Market Realist
Jun-29-17 05:24PM  No Sell Ratings for Abbott: Wall Street Is Confident Market Realist
03:31PM  Guggenheim Starts Covering Abbott Laboratories GuruFocus.com
01:32PM  Abbott Secures Health Canada License for FreeStyle® Libre System for People with Diabetes PR Newswire
12:33PM  5 Underfollowed Stocks That Are Projected To Explode Zacks
10:20AM  Anadarko, Abbott Labs Are Buys Before They Soar Double Digits -- Analysts TheStreet.com
Jun-28-17 04:05PM  Could Philips' Rivals Stage A Coup For Spectranetics? Investor's Business Daily
Jun-27-17 08:38AM  The Forgotten $35 Billion U.S. Healthcare Problem Forbes
Jun-26-17 03:12PM  ETFs with exposure to Abbott Laboratories : June 26, 2017 Capital Cube
Jun-23-17 01:32PM  Top Stock Reports for Oracle, Allergan & Abbott Zacks
11:00AM  Why This Healthcare ETF Is Surging Investopedia
Jun-21-17 09:00AM  Abbott Hosts Conference Call for Second-Quarter Earnings PR Newswire
Jun-20-17 05:37PM  How to Uncover Institutional Buying Zacks
Jun-19-17 11:51AM  Abbott Laboratories :ABT-US: Earnings Analysis: Q1, 2017 By the Numbers : June 19, 2017 Capital Cube
09:08AM  How Strykers Margins Are Driven by Its CTG Program Market Realist
Jun-16-17 02:35PM  2 Solid Medical Device Stocks to Scoop Up Right Away Zacks
Jun-15-17 12:52PM  ETFs with exposure to Abbott Laboratories : June 15, 2017 Capital Cube
09:30AM  The Zacks Analyst Blog Highlights: United Technologies, Abbott, Delta Air, Equity Residential and Ross Stores Zacks
09:26AM  Abbott Laboratories Up on EPD & Buyouts, Pediatric Weak Zacks
06:00AM  Alere says feds wont take action in billing probe American City Business Journals
Jun-14-17 12:10PM  Top Stock Reports for United Technologies, Abbott, Delta Air & Others Zacks
Jun-12-17 09:39AM  Abbott Laboratories Saw a Recent Breakout TheStreet.com
Jun-09-17 04:15PM  AbbVie must pay $15 mln in Depakote birth-defect trial: jury Reuters
03:56PM  Abbott Labs Declares Quarterly Dividend GuruFocus.com
03:35PM  FDA Approval Boosts Baxters Generic Injectable Business Market Realist
12:41PM  AbbVie Ordered by Jury to Pay $15 Million to Depakote Victim Bloomberg
10:15AM  Abbott Declares 374th Consecutive Quarterly Dividend PR Newswire
Jun-07-17 09:30AM  Birmingham health exec enters governor's race American City Business Journals
Jun-06-17 09:31AM  Biotech Movers: Albany Molecular Shares Soar on Sale to PE Firms TheStreet.com
Jun-05-17 10:35AM  Abbott Laboratories at 52-Week High on Product Line, Buyouts Zacks
Jun-03-17 02:04PM  3 Best Dividend Stocks in the Medical Device Industry Motley Fool
Jun-02-17 09:30AM  The Zacks Analyst Blog Highlights: McCormick & Company, S&P Global, Sherwin-Williams, 3M and Abbott Laboratories Zacks
May-30-17 09:30AM  The Zacks Analyst Blog Highlights: Visa, General Electric, GlaxoSmithKline, Morgan Stanley and Abbott Laboratories Zacks
07:36AM  Abbott Is Expected to Report a Modest Rise in Net Profit Margins Market Realist
May-29-17 10:36AM  Why Abbott Is Expected to Report Robust Revenue Growth in 2017 Market Realist
09:06AM  Abbott Laboratories Still Dominates the Medical Device Segment Market Realist
08:10AM  Abbott Laboratories breached its 50 day moving average in a Bullish Manner : ABT-US : May 29, 2017 Capital Cube
07:36AM  Global Markets May Drive Established Pharmaceuticals Growth Market Realist
May-26-17 12:44PM  Top Analyst Reports for Visa, GE, GlaxoSmithKline & Others Zacks
10:37AM  Abbott Continues to Expand Its Diagnostics Portfolio in 2017 Market Realist
09:07AM  Emerging Markets Drive Abbotts Nutritional Business Growth Market Realist
07:37AM  St. Jude Medical May Establish ABT as a Key Medical Device Player Market Realist
May-25-17 05:35PM  How Will Abbott Laboratories Benefit from Its Alere Acquisition? Market Realist
03:54PM  Analysts Recommendations for Abbott Laboratories in May 2017 Market Realist
Abbott Laboratories manufactures and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; cardiovascular and metabolic products; and influenza vaccines, as well as to regulate physiological rhythm of the colon. Its Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments to automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; informatics and automation solutions; and a suite of informatics tools and professional services. The company's Nutritional Products segment provides pediatric and adult nutritional products. Its Vascular Products segment offers coronary, endovascular, vessel closure, and structural heart devices to treat vascular disease. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in North Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Watkin JaredSenior Vice PresidentJun 15Sale47.9755226,48246,538Jun 16 05:02 PM
Fussell Stephen RExecutive Vice PresidentJun 08Option Exercise25.56196,5505,023,939378,688Jun 09 05:04 PM
Fussell Stephen RExecutive Vice PresidentJun 08Sale46.00196,5509,041,360182,138Jun 09 05:04 PM
BIRD ROGERSenior Vice PresidentApr 27Sale43.825,600245,39351,313Apr 28 05:28 PM
MANNING JOSEPH JSenior Vice PresidentApr 26Option Exercise26.703,20085,43126,224Apr 28 05:27 PM
MANNING JOSEPH JSenior Vice PresidentApr 26Sale43.954,200184,59922,024Apr 28 05:27 PM
Contreras JaimeSenior Vice PresidentMar 31Sale44.6476734,2402,410Apr 04 05:02 PM
YOOR BRIAN BExecutive Vice President & CFOMar 01Sale45.391,72878,43463,425Mar 02 05:19 PM
NATH DEEPAK S.Senior Vice PresidentMar 01Sale45.391,60172,66951,430Mar 02 05:17 PM
Watkin JaredSenior Vice PresidentMar 01Sale45.3997044,02848,511Mar 02 05:12 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentMar 01Sale45.392,06693,77672,112Mar 02 05:16 PM
Warmuth Michael JExecutive Vice PresidentMar 01Sale45.393,851174,79756,508Mar 02 05:04 PM
Contreras JaimeSenior Vice PresidentFeb 28Sale45.0113,155592,15745,733Mar 02 05:05 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 28Sale45.0185738,569100,879Mar 02 05:15 PM
BIRD ROGERSenior Vice PresidentFeb 28Sale45.021,60172,06956,913Mar 02 05:11 PM
Mason Heather LExecutive Vice PresidentFeb 28Sale45.011,91286,06859,677Mar 02 05:06 PM
MANNING JOSEPH JSenior Vice PresidentFeb 28Sale44.9674433,45323,024Mar 02 05:18 PM
Funck Robert EVice President, ControllerFeb 23Option Exercise26.7025,500680,781117,579Feb 24 05:28 PM
Funck Robert EVice President, ControllerFeb 23Sale45.5025,5001,160,25092,079Feb 24 05:28 PM
BIRD ROGERSenior Vice PresidentFeb 22Option Exercise26.6212,903343,53975,767Feb 22 05:59 PM
BIRD ROGERSenior Vice PresidentFeb 22Sale45.0212,903580,93862,864Feb 22 05:59 PM
CAPEK JOHN MExecutive Vice PresidentFeb 21Option Exercise26.7093,4002,493,528382,197Feb 22 05:57 PM
BIRD ROGERSenior Vice PresidentFeb 21Sale44.9431914,33562,864Feb 22 05:59 PM
CAPEK JOHN MExecutive Vice PresidentFeb 21Sale45.0093,4004,203,000288,797Feb 22 05:57 PM
Watkin JaredSenior Vice PresidentFeb 21Sale44.9855524,96551,977Feb 22 05:57 PM
NATH DEEPAK S.Senior Vice PresidentFeb 21Sale44.9831914,34957,333Feb 22 05:34 PM
MANNING JOSEPH JSenior Vice PresidentFeb 21Sale44.981466,56720,146Feb 22 06:18 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 13Option Exercise25.253,40085,83791,857Feb 15 05:04 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 13Sale43.003,400146,20088,457Feb 15 05:04 PM
MANNING JOSEPH JSenior Vice PresidentFeb 03Option Exercise25.253007,57420,792Feb 07 05:02 PM
Mason Heather LExecutive Vice PresidentJan 31Option Exercise25.2535,700901,286100,189Feb 02 05:31 PM
Fussell Stephen RExecutive Vice PresidentJan 31Buy40.7712,200497,394167,167Feb 02 05:32 PM
Mason Heather LExecutive Vice PresidentJan 31Sale40.7735,7001,455,48964,489Feb 02 05:31 PM
Blaser Brian JExecutive Vice PresidentDec 20Buy38.4515,580599,120145,062Dec 21 02:19 PM
Ford Robert BExecutive Vice PresidentDec 14Buy39.0912,775499,34569,542Dec 16 05:07 PM
CAPEK JOHN MExecutive Vice PresidentNov 16Option Exercise24.3822,000536,386274,524Nov 18 05:02 PM
WHITE MILES DChairman and CEONov 10Buy40.6758,2632,369,4483,111,967Nov 14 10:04 AM
WHITE MILES DChairman and CEONov 10Buy40.5389,5783,630,2943,004,943Nov 14 10:03 AM
WHITE MILES DChairman and CEONov 10Buy40.6548,7611,982,0793,053,704Nov 14 10:03 AM
WHITE MILES DChairman and CEONov 10Buy40.5451,8922,103,4552,793,909Nov 14 10:02 AM
WHITE MILES DChairman and CEONov 10Buy40.45121,4564,912,7412,915,365Nov 14 10:02 AM
Blount Sally E.DirectorNov 01Buy39.245,100200,12420,143Nov 02 05:12 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentSep 26Sale41.7181533,99458,976Sep 28 05:05 PM
FREYMAN THOMAS CExecutive Vice PresidentJul 29Option Exercise25.2556,0001,413,782438,682Jul 29 05:04 PM
Fussell Stephen RExecutive Vice PresidentJul 28Option Exercise25.2541,5001,047,713196,467Jul 29 05:03 PM
Fussell Stephen RExecutive Vice PresidentJul 28Sale45.0041,5001,867,640154,967Jul 29 05:03 PM
Warmuth Michael JExecutive Vice PresidentJul 26Option Exercise25.2526,800676,59581,811Jul 27 04:43 PM
Warmuth Michael JExecutive Vice PresidentJul 26Sale43.4926,8001,165,45755,011Jul 27 04:43 PM
WHITE MILES DChairman and CEOJul 25Option Exercise25.25550,00013,885,3552,010,517Jul 27 04:27 PM
Funck Robert EVice President, ControllerJul 25Option Exercise25.2526,800676,595111,819Jul 27 04:44 PM
WHITE MILES DChairman and CEOJul 25Buy43.3417,933777,1622,742,017Jul 27 04:31 PM
WHITE MILES DChairman and CEOJul 25Buy43.26176,8047,648,8232,724,084Jul 27 04:30 PM
WHITE MILES DChairman and CEOJul 25Buy43.19181,2637,828,6282,434,327Jul 27 04:29 PM
WHITE MILES DChairman and CEOJul 25Buy43.34112,9534,895,2172,547,280Jul 27 04:29 PM
WHITE MILES DChairman and CEOJul 25Buy43.18242,54710,472,9392,253,064Jul 27 04:27 PM
Funck Robert EVice President, ControllerJul 25Sale43.0826,8001,154,54485,019Jul 27 04:44 PM